# Kidney Disease: Improving Global Outcomes (KDIGO)

Organization · id `cardio:kdigo` · Cardiovascular Atlas · release `73130c34862e2d06` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

Also called: KDIGO

Browse, organ or system: Kidneys  
Browse, condition area: Kidney connections  

## In plain language

An international nonprofit organization for kidney disease. A work group under its name wrote the 2022 guideline on diabetes management in chronic kidney disease that is recorded in this atlas.

## Technical summary

ROR record 02v233898 gives the name Kidney Disease: Improving Global Outcomes, the acronym KDIGO, the types funder and nonprofit, and Brussels as its location. The PubMed record of the 2022 guideline names the KDIGO Diabetes Work Group as author. Nothing else about the organization was read.

## Connected pages

- Authored: ADA/KDIGO 2022 consensus report on diabetes management in CKD (`cardio:guideline-ada-kdigo-2022-consensus`)
- Authored: KDIGO 2022 guideline for diabetes management in CKD (`cardio:guideline-kdigo-2022-diabetes-ckd`)

## Provenance

Content hash: 513ce61343dbd973df7435355a32dd4ab8dbe1910e619666a184d6a2a13327d0
Last substantive edit: 2026-10-15
Evidence last checked: 2026-10-15